Latest news with #Iofina
Yahoo
18-07-2025
- Business
- Yahoo
UK Penny Stocks To Watch In July 2025
The UK market has recently faced challenges, with the FTSE 100 index closing lower amid weak trade data from China, highlighting global economic uncertainties. Despite these broader market concerns, penny stocks remain an intriguing investment area for those seeking potential growth opportunities. While traditionally associated with smaller or newer companies, these stocks can offer significant value when backed by strong financials and solid fundamentals. Top 10 Penny Stocks In The United Kingdom Name Share Price Market Cap Financial Health Rating FRP Advisory Group (AIM:FRP) £1.215 £301.38M ★★★★★☆ Warpaint London (AIM:W7L) £4.25 £343.35M ★★★★★★ Van Elle Holdings (AIM:VANL) £0.395 £42.74M ★★★★★★ System1 Group (AIM:SYS1) £4.25 £53.93M ★★★★★★ LSL Property Services (LSE:LSL) £3.05 £314.04M ★★★★★☆ Alumasc Group (AIM:ALU) £3.45 £124.07M ★★★★★★ Begbies Traynor Group (AIM:BEG) £1.21 £193.04M ★★★★★★ Croma Security Solutions Group (AIM:CSSG) £0.82 £11.29M ★★★★★★ Braemar (LSE:BMS) £2.19 £67.66M ★★★★★★ ME Group International (LSE:MEGP) £2.14 £808.09M ★★★★★★ Click here to see the full list of 295 stocks from our UK Penny Stocks screener. We're going to check out a few of the best picks from our screener tool. Iofina Simply Wall St Financial Health Rating: ★★★★★★ Overview: Iofina plc explores, develops, and produces iodine and halogen-based specialty chemical derivatives from oil and gas operations across North America, Asia, South America, Europe, and internationally with a market cap of £52.28 million. Operations: The company's revenue is primarily derived from its Halogen Derivatives and Iodine segment, which generated $54.47 million. Market Cap: £52.28M Iofina plc, with a market cap of £52.28 million, has demonstrated financial resilience despite recent challenges. The company reported US$54.47 million in revenue for 2024, although net income decreased to US$2.92 million from the previous year's US$6.56 million, reflecting a drop in profit margins to 5.4%. Despite this decline, Iofina's debt situation is favorable with more cash than total debt and well-covered interest payments by EBIT (31.4x). The management team and board are experienced, contributing to stable operations amidst volatile earnings growth (-55.5% last year), yet revenue is projected to grow annually by 12.68%. Navigate through the intricacies of Iofina with our comprehensive balance sheet health report here. Learn about Iofina's future growth trajectory here. Supreme Simply Wall St Financial Health Rating: ★★★★★★ Overview: Supreme Plc is involved in the ownership, manufacturing, and distribution of batteries, lighting, vaping products, sports nutrition and wellness items, and branded household consumer goods across the UK, Ireland, the Netherlands, France, Europe at large and internationally with a market cap of £213.52 million. Operations: Supreme generates its revenue from three main segments: Vaping (£128.95 million), Electricals (£53.37 million), and Drinks & Wellness (£48.76 million). Market Cap: £213.52M Supreme Plc, with a market cap of £213.52 million, reported solid financial performance with revenue of £231.08 million and net income of £23.46 million for the year ended March 31, 2025. The company is trading at a significant discount to its estimated fair value and maintains strong financial health with more cash than total debt and well-covered interest payments by EBIT (25.3x). Despite recent earnings growth slowing to 4.6%, Supreme's historical profit growth has been robust at an average of 21.8% annually over five years, although future earnings are forecasted to decline by an average of 5.9% per year over the next three years. Dive into the specifics of Supreme here with our thorough balance sheet health report. Understand Supreme's earnings outlook by examining our growth report. Genel Energy Simply Wall St Financial Health Rating: ★★★★★★ Overview: Genel Energy plc is an independent oil and gas exploration and production company with a market cap of £179.52 million. Operations: Genel Energy's revenue primarily comes from its production segment, generating $74.7 million. Market Cap: £179.52M Genel Energy, with a market cap of £179.52 million, is experiencing robust production growth, reporting 82,081 bopd in Q1 2025. Despite being unprofitable and not expected to turn profitable in the next three years, the company maintains financial stability with short-term assets exceeding liabilities and more cash than total debt. Its share price has been highly volatile recently but trades significantly below estimated fair value. Genel's management and board are experienced, while its cash runway extends beyond three years even as free cash flow shrinks by 14% annually. The company has also reduced its debt-to-equity ratio over five years. Take a closer look at Genel Energy's potential here in our financial health report. Review our growth performance report to gain insights into Genel Energy's future. Next Steps Get an in-depth perspective on all 295 UK Penny Stocks by using our screener here. Contemplating Other Strategies? Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include AIM:IOF AIM:SUP and LSE:GENL. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
06-06-2025
- Business
- Yahoo
3 Promising UK Penny Stocks With Market Caps Over £50M
The UK market has recently faced challenges, with the FTSE 100 index faltering due to weak trade data from China, highlighting global economic interdependencies. Despite these broader market pressures, certain investment opportunities remain attractive. Penny stocks, although an outdated term, continue to represent smaller or less-established companies that can offer value and growth potential when backed by strong financials. In this article, we will explore three such UK penny stocks that stand out for their financial health and potential for future growth. Name Share Price Market Cap Financial Health Rating Foresight Group Holdings (LSE:FSG) £3.96 £445.67M ★★★★★★ Warpaint London (AIM:W7L) £4.55 £367.58M ★★★★★★ Cairn Homes (LSE:CRN) £1.86 £1.16B ★★★★★☆ Van Elle Holdings (AIM:VANL) £0.365 £39.49M ★★★★★★ Helios Underwriting (AIM:HUW) £2.34 £169.52M ★★★★★☆ Polar Capital Holdings (AIM:POLR) £4.345 £418.91M ★★★★★★ LSL Property Services (LSE:LSL) £2.88 £297.56M ★★★★★☆ Begbies Traynor Group (AIM:BEG) £1.04 £165.92M ★★★★★★ Croma Security Solutions Group (AIM:CSSG) £0.86 £11.84M ★★★★★★ Braemar (LSE:BMS) £2.31 £72.32M ★★★★★★ Click here to see the full list of 401 stocks from our UK Penny Stocks screener. Let's take a closer look at a couple of our picks from the screened companies. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Iofina plc, with a market cap of £50.27 million, explores, develops, and produces iodine and halogen-based specialty chemical derivatives from oil and gas operations in the United States and the United Kingdom. Operations: The company's revenue is primarily generated from halogen derivatives and iodine, amounting to $54.47 million. Market Cap: £50.27M Iofina plc, with a market cap of £50.27 million, is positioned within the penny stock segment due to its valuation and operational scale. The company reported revenue of US$54.47 million for 2024, showing modest growth from the previous year but faced a decline in net income to US$2.92 million from US$6.56 million. Despite stable weekly volatility and high-quality earnings, Iofina's profit margins have decreased significantly over the past year, and it lowered its iodine production guidance for early 2025. However, strong asset coverage and reduced debt levels enhance its financial resilience amidst these challenges. Jump into the full analysis health report here for a deeper understanding of Iofina. Evaluate Iofina's prospects by accessing our earnings growth report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Ramsdens Holdings PLC provides diversified financial services both in the United Kingdom and internationally, with a market capitalization of £112.70 million. Operations: Ramsdens Holdings PLC does not report specific revenue segments. Market Cap: £112.7M Ramsdens Holdings PLC, with a market cap of £112.70 million, demonstrates robust financial health within the penny stock category. The company reported half-year sales of £51.6 million and net income of £4.43 million, up from the previous year, indicating strong earnings growth. Its seasoned management team has overseen an increase in net profit margins and a stable debt profile supported by more cash than total debt. Recent announcements include plans to expand store openings and an increased interim dividend by 25% to 4.5 pence per share, highlighting its commitment to shareholder returns amidst ongoing business expansion efforts. Take a closer look at Ramsdens Holdings' potential here in our financial health report. Understand Ramsdens Holdings' earnings outlook by examining our growth report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Focusrite plc develops, manufactures, and markets professional audio and electronic music products globally, with a market cap of £105.52 million. Operations: The company's revenue is derived from various segments, including Focusrite (£61.79 million), Novation (£17.07 million), ADAM Audio (£24.972 million), Martin Audio (£46.38 million), Sequential (£10.418 million), and Sonnox (£1.917 million). Market Cap: £105.52M Focusrite plc, with a market cap of £105.52 million, shows mixed signals in the penny stock arena. While earnings are forecast to grow at 35% annually, recent net profit margins have declined from 7% to 1.2%. The company's revenue for the first half of 2025 increased to £80.91 million from £76.88 million a year prior, but net income decreased to £1.84 million from £2.47 million. Despite high volatility and low return on equity (1.7%), Focusrite maintains satisfactory debt levels and strong short-term asset coverage over liabilities, supporting its financial stability amidst fluctuating performance metrics. Dive into the specifics of Focusrite here with our thorough balance sheet health report. Learn about Focusrite's future growth trajectory here. Investigate our full lineup of 401 UK Penny Stocks right here. Interested In Other Possibilities? Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 24 best rare earth metal stocks of the very few that mine this essential strategic resource. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include AIM:IOF AIM:RFX and AIM:TUNE. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13-05-2025
- Business
- Yahoo
Iofina plc's (LON:IOF) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Iofina's (LON:IOF) stock is up by a considerable 13% over the past month. As most would know, fundamentals are what usually guide market price movements over the long-term, so we decided to look at the company's key financial indicators today to determine if they have any role to play in the recent price movement. In this article, we decided to focus on Iofina's ROE. ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. In simpler terms, it measures the profitability of a company in relation to shareholder's equity. Our free stock report includes 2 warning signs investors should be aware of before investing in Iofina. Read for free now. Return on equity can be calculated by using the formula: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for Iofina is: 7.9% = US$3.6m ÷ US$45m (Based on the trailing twelve months to December 2024). The 'return' is the income the business earned over the last year. One way to conceptualize this is that for each £1 of shareholders' capital it has, the company made £0.08 in profit. View our latest analysis for Iofina We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. Based on how much of its profits the company chooses to reinvest or "retain", we are then able to evaluate a company's future ability to generate profits. Assuming all else is equal, companies that have both a higher return on equity and higher profit retention are usually the ones that have a higher growth rate when compared to companies that don't have the same features. When you first look at it, Iofina's ROE doesn't look that attractive. However, given that the company's ROE is similar to the average industry ROE of 7.4%, we may spare it some thought. Particularly, the exceptional 27% net income growth seen by Iofina over the past five years is pretty remarkable. Considering the moderately low ROE, it is quite possible that there might be some other aspects that are positively influencing the company's earnings growth. For instance, the company has a low payout ratio or is being managed efficiently. As a next step, we compared Iofina's net income growth with the industry, and pleasingly, we found that the growth seen by the company is higher than the average industry growth of 0.4%. Earnings growth is a huge factor in stock valuation. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. This then helps them determine if the stock is placed for a bright or bleak future. If you're wondering about Iofina's's valuation, check out this gauge of its price-to-earnings ratio, as compared to its industry. Iofina doesn't pay any regular dividends to its shareholders, meaning that the company has been reinvesting all of its profits into the business. This is likely what's driving the high earnings growth number discussed above. Overall, we feel that Iofina certainly does have some positive factors to consider. With a high rate of reinvestment, albeit at a low ROE, the company has managed to see a considerable growth in its earnings. While we won't completely dismiss the company, what we would do, is try to ascertain how risky the business is to make a more informed decision around the company. You can see the 2 risks we have identified for Iofina by visiting our risks dashboard for free on our platform here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
05-03-2025
- Business
- Yahoo
Investing in Iofina (LON:IOF) three years ago would have delivered you a 22% gain
By buying an index fund, investors can approximate the average market return. But many of us dare to dream of bigger returns, and build a portfolio ourselves. Just take a look at Iofina plc (LON:IOF), which is up 22%, over three years, soundly beating the market return of 10% (not including dividends). So let's investigate and see if the longer term performance of the company has been in line with the underlying business' progress. Check out our latest analysis for Iofina There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price. Iofina was able to grow its EPS at 1.5% per year over three years, sending the share price higher. In comparison, the 7% per year gain in the share price outpaces the EPS growth. This indicates that the market is feeling more optimistic on the stock, after the last few years of progress. It is quite common to see investors become enamoured with a business, after a few years of solid progress. The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers). This free interactive report on Iofina's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further. Investors in Iofina had a tough year, with a total loss of 6.5%, against a market gain of about 15%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Longer term investors wouldn't be so upset, since they would have made 2%, each year, over five years. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Take risks, for example - Iofina has 2 warning signs we think you should be aware of. We will like Iofina better if we see some big insider buys. While we wait, check out this free list of undervalued stocks (mostly small caps) with considerable, recent, insider buying. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on British exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
